Dominant negative mutant forms of the cAMP response element binding protein induce apoptosis and decrease the...

Area of Science:

• Cell Biology
• Endocrinology
• Transplantation Science

Background:

• Islet transplantation is a promising treatment for diabetes.
• Islet loss due to apoptosis is a major challenge in transplantation.
• cAMP response element binding protein (CREB) is a key factor in cell survival.

Purpose of the Study:

• To investigate the necessity of CREB function for human islet survival.
• To determine if CREB preservation is vital for successful islet transplantation.

Main Methods:

• Human islets were transduced with adenoviral vectors expressing dominant-negative CREB mutants.
• Apoptosis markers were assessed under basal conditions and after growth factor treatment.
• Downregulation of CREB activity effects on beta cell apoptosis were analyzed.

Main Results:

• CREB mutant expression significantly activated caspase-9, a key apoptosis regulator, in human islets.
• Apoptosis markers including caspase-3 activation and nuclear condensation were observed.
• The anti-apoptotic effects of growth factors exendin-4 and betacellulin were diminished when CREB function was impaired.

Conclusions:

• Impairment of CREB-mediated transcription leads to islet loss via apoptosis.
• These findings have implications for improving islet transplantation outcomes.
• Understanding CREB's role is critical for addressing beta cell loss in diabetes.